172 related articles for article (PubMed ID: 10781009)
1. Ecto-nucleotide pyrophosphatase modulates the purinoceptor-mediated signal transduction and is inhibited by purinoceptor antagonists.
Grobben B; Claes P; Roymans D; Esmans EL; Van Onckelen H; Slegers H
Br J Pharmacol; 2000 May; 130(1):139-45. PubMed ID: 10781009
[TBL] [Abstract][Full Text] [Related]
2. Two subtypes of G protein-coupled nucleotide receptors, P2Y(1) and P2Y(2) are involved in calcium signalling in glioma C6 cells.
Sabala P; Czajkowski R; Przybyłek K; Kalita K; Kaczmarek L; Barańska J
Br J Pharmacol; 2001 Jan; 132(2):393-402. PubMed ID: 11159687
[TBL] [Abstract][Full Text] [Related]
3. Different signal transduction pathways are coupled to the nucleotide receptor and the P2Y receptor in C6 glioma cells.
Lin WW; Chuang DM
J Pharmacol Exp Ther; 1994 Jun; 269(3):926-31. PubMed ID: 8014879
[TBL] [Abstract][Full Text] [Related]
4. An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma.
Grobben B; Anciaux K; Roymans D; Stefan C; Bollen M; Esmans EL; Slegers H
J Neurochem; 1999 Feb; 72(2):826-34. PubMed ID: 9930759
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors.
Boyer JL; Zohn IE; Jacobson KA; Harden TK
Br J Pharmacol; 1994 Oct; 113(2):614-20. PubMed ID: 7834215
[TBL] [Abstract][Full Text] [Related]
6. P2Y(AC)(-)-receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinase.
Claes P; Grobben B; Van Kolen K; Roymans D; Slegers H
Br J Pharmacol; 2001 Sep; 134(2):402-8. PubMed ID: 11564659
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages.
Chen BC; Lee CM; Lin WW
Br J Pharmacol; 1996 Dec; 119(8):1628-34. PubMed ID: 8982511
[TBL] [Abstract][Full Text] [Related]
8. ATP released from astrocytes during swelling activates chloride channels.
Darby M; Kuzmiski JB; Panenka W; Feighan D; MacVicar BA
J Neurophysiol; 2003 Apr; 89(4):1870-7. PubMed ID: 12686569
[TBL] [Abstract][Full Text] [Related]
9. Functional characterisation of P2 purinoceptors in PC12 cells by measurement of radiolabelled calcium influx.
Michel AD; Grahames CB; Humphrey PP
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):562-71. PubMed ID: 8938653
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of some purinergic agents on ecto-ATPase activity and pattern of stepwise ATP hydrolysis in rat liver plasma membranes.
Yegutkin GG; Burnstock G
Biochim Biophys Acta; 2000 Jun; 1466(1-2):234-44. PubMed ID: 10825445
[TBL] [Abstract][Full Text] [Related]
11. The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase.
Webb TE; Feolde E; Vigne P; Neary JT; Runberg A; Frelin C; Barnard EA
Br J Pharmacol; 1996 Dec; 119(7):1385-92. PubMed ID: 8968547
[TBL] [Abstract][Full Text] [Related]
12. Effects of P2-purinoceptor antagonists on ecto-nucleotidase activity of guinea-pig vas deferens cultured smooth muscle cells.
Ziganshin AU; Ziganshina LE; Bodin P; Bailey D; Burnstock G
Biochem Mol Biol Int; 1995 Jul; 36(4):863-9. PubMed ID: 8528149
[TBL] [Abstract][Full Text] [Related]
13. Complexities of measuring antagonist potency at P2X(7) receptor orthologs.
Hibell AD; Thompson KM; Xing M; Humphrey PP; Michel AD
J Pharmacol Exp Ther; 2001 Mar; 296(3):947-57. PubMed ID: 11181928
[TBL] [Abstract][Full Text] [Related]
14. Two types of relaxation-mediating P2 receptors in rat gastric circular muscle.
Otsuguro K; Ohta T; Ito S; Nakazato Y
Jpn J Pharmacol; 1998 Oct; 78(2):209-15. PubMed ID: 9829624
[TBL] [Abstract][Full Text] [Related]
15. PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors.
Charlton SJ; Brown CA; Weisman GA; Turner JT; Erb L; Boarder MR
Br J Pharmacol; 1996 Jun; 118(3):704-10. PubMed ID: 8762097
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ecto-ATPase by the P2 purinoceptor agonists, ATPgammaS, alpha,beta-methylene-ATP, and AMP-PNP, in endothelial cells.
Chen BC; Lin WW
Biochem Biophys Res Commun; 1997 Apr; 233(2):442-6. PubMed ID: 9144554
[TBL] [Abstract][Full Text] [Related]
17. Reactive blue 2 inhibition of cyclic AMP-dependent differentiation of rat C6 glioma cells by purinergic receptor-independent inactivation of phosphatidylinositol 3-kinase.
Claes P; Van Kolen K; Roymans D; Blero D; Vissenberg K; Erneux C; Verbelen JP; Esmans EL; Slegers H
Biochem Pharmacol; 2004 Apr; 67(8):1489-98. PubMed ID: 15041466
[TBL] [Abstract][Full Text] [Related]
18. Evidence that rat hepatocytes co-express functional P2Y1 and P2Y2 receptors.
Dixon CJ; Woods NM; Webb TE; Green AK
Br J Pharmacol; 2000 Feb; 129(4):764-70. PubMed ID: 10683201
[TBL] [Abstract][Full Text] [Related]
19. Multiple motor effects of ATP and their inhibition by P purinoceptor antagonist, pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid in the small intestine of the guinea-pig.
Barthó L; Undi S; Benkó R; Wolf M; Lázár Z; Lénárd L; Maggi CA
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):488-95. PubMed ID: 16635108
[TBL] [Abstract][Full Text] [Related]
20. Correlation between adenine nucleotide-induced cyclic AMP elevation and extracellular adenosine formation in NG108-15 cells.
Ohkubo S; Kimura J; Matsuoka I
Jpn J Pharmacol; 2000 Nov; 84(3):325-33. PubMed ID: 11138734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
